Finance entity
All 1 tracked stories fall under one category: earnings. MarketBeat is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 5.4 for that window. Each story carries 2 original sources on average, compared with 2.2 for the broader beat in this window.
Last mentioned: 4d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: earnings. MarketBeat is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 5.4 for that window. Each story carries 2 original sources on average, compared with 2.2 for the broader beat in this window. USANA Health Sciences appears in 1 tracked Finance story from August 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 44 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering USANA Health Sciences. Shared-story counts are live from our verified record — not editorial picks.
USANA Health Sciences stunned the Street with fiscal 2026 earnings guidance of just $0.76 per share, 64% below consensus, and revenue of $910 million—following a quarterly loss of $0.07. With analyst consensus dropping to Reduce and the stock trading near its 52-week low, investors are reassessing valuation and downside risk.
Source: themarketsdaily.com · dailypolitical.com
USANA Health Sciences is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
